FDA approves new #nasal spray to treat #migraine #headaches in adults

📌 The nasal spray #zavegepant, sold as #Zavzpret, may relieve pain and other bothersome migraine symptoms as soon as 15 minutes after use, drugmaker Pfizer said in a news release. The drug is expected to be available in pharmacies in July 2023

📌 Zavzpret works by blocking the calcitonin gene-related peptide, CGRP, a protein that is released in the brain that contributes to inflammation

https://edition.cnn.com/2023/03/10/health/migraine-nasal-spray-zavzpret/index.html